IDENTIFICATION OF MAJOR PROGNOSTIC SUBGROUPS OF PATIENTS WITH LARGE-CELL LYMPHOMA TREATED WITH M-BACOD OR M-BACOD

被引：302

作者：

SHIPP, MA

HARRINGTON, DP

KLATT, MM

JOCHELSON, MS

PINKUS, GS

MARSHALL, JL

ROSENTHAL, DS

SKARIN, AT

CANELLOS, GP

机构：

[1] HARVARD UNIV, SCH MED,DANA FARBER CANC INST, DEPT MED & MED ONCOL,DIV MED ONCOL,44 BINNEY ST, BOSTON, MA 02115 USA

[2] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DIV BIOSTAT, BOSTON, MA 02115 USA

[3] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DIV RADIOL, BOSTON, MA 02115 USA

[4] HARVARD UNIV, BRIGHAM & WOMENS HOSP, DEPT MED, DIV HEMATOL, BOSTON, MA 02115 USA

来源：

ANNALS OF INTERNAL MEDICINE | 1986年 / 104卷 / 06期

关键词：

D O I：

10.7326/0003-4819-104-6-757

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：757 / 765

页数：9

共 45 条

[1]

ARMITAGE JO, 1982, CANCER, V50, P1695, DOI 10.1002/1097-0142(19821101)50:9<1695::AID-CNCR2820500907>3.0.CO

[2]

2-H

[3] CLINICAL UTILITY OF LYMPHOCYTE SURFACE-MARKERS COMBINED WITH THE LUKES-COLLINS HISTOLOGIC CLASSIFICATION IN ADULT LYMPHOMA [J].

BLOOMFIELD, CD ;

GAJLPECZALSKA, KJ ;

FRIZZERA, G ;

KERSEY, JH ;

GOLDMAN, AI .

NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (10) :512-518

[4] FACTORS PREDICTING FOR RESPONSE AND SURVIVAL IN ADULTS WITH ADVANCED NON-HODGKINS LYMPHOMA [J].

CABANILLAS, F ;

BURKE, JS ;

SMITH, TL ;

MOON, TE ;

BUTLER, JJ ;

RODRIGUEZ, V .

ARCHIVES OF INTERNAL MEDICINE, 1978, 138 (03) :413-418

[5]

CHANG CH, 1983, CANCER, V52, P997, DOI 10.1002/1097-0142(19830915)52:6<997::AID-CNCR2820520612>3.0.CO

[6]

2-2

[7] CHEMOTHERAPY FOR LARGE-CELL LYMPHOMA - OPTIMISM AND CAUTION [J].

COLEMAN, M .

ANNALS OF INTERNAL MEDICINE, 1985, 103 (01) :140-142

[8]

COX DR, 1972, J R STAT SOC B, V34, P187

[9]

Cox DR., 1990, BIOMETRICS, V46, P550, DOI DOI 10.2307/2531476

[10]

CREAGAN ET, 1984, CANCER, V54, P2844, DOI 10.1002/1097-0142(19841215)54:12<2844::AID-CNCR2820541205>3.0.CO

← 1 2 3 4 5 →